Integral Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Sell
2,159
-71
-3% -$8.31K 0.06% 153
2026
Q1
$268K Sell
2,230
-73
-3% -$8.43K 0.07% 151
2025
Q4
$242K Buy
+2,303
New +$216K 0.06% 162
2025
Q1
Sell
-3,403
Closed -$339K 160
2024
Q4
$339K Sell
3,403
-79
-2% -$8.14K 0.11% 118
2024
Q3
$395K Sell
3,482
-198
-5% -$23.5K 0.13% 110
2024
Q2
$478K Buy
3,680
+584
+19% +$75.2K 0.18% 94
2024
Q1
$408K Buy
+3,096
New +$382K 0.17% 100

Other funds holding MRK

Integral Investment Advisors's MRK Position: Q2 2026 in Review

Integral Investment Advisors reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $8.31K and leaving 2,159 shares worth $277K. The position accounts for 0.06% of the portfolio, ranked #153.

Integral Investment Advisors first reported a position in MRK in Q1 2024 and has held it in 7 quarters since. The position peaked at $478K in Q2 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Integral Investment Advisors held 2,159 shares of Merck worth $277K as of Q2 2026.
  • Integral Investment Advisors sold 71 Merck shares in Q2 2026, an estimated $8.31K.
  • Merck made up 0.06% of Integral Investment Advisors's portfolio in Q2 2026, its #153 holding.
  • Integral Investment Advisors first reported a position in Merck in Q1 2024 and has held it in 7 quarters since.
  • Integral Investment Advisors's Merck position peaked at $478K in Q2 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.